Home > ARTIS

What is ARTIS?

 

ARTIS – AntiRheumatic Therapy In Sweden – is one of SRF’s study groups. The group was formed when the first TNF inhibitors were approved for the treatment of RA. The focus has been on monitoring the safety of biological drugs, but the group’s work has gradually also come to include issues such as effect, comorbidity and epidemiological methodology.

The group has representatives from all health care regions, but also has other members with a special interest in drug monitoring. Current information about who is included in the group can be found on SRF’s website.

To the ARTIS Group on the SRF website




			

			

				
				
				
				
				
			

				
				
				
				
			

				

				
				
				
				
				

				
				
				
				
				

					

					

						
 ARTIS monitors the safety of biological drugs but also analyzes areas such as efficacy, comorbidity and epidemiological methodology.